FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2940259738> ?p ?o ?g. }

• W2940259738 endingPage "915" @default.
• W2940259738 startingPage "912" @default.
• W2940259738 abstract "Clinical trials demonstrated intermittent preventive treatment in pregnancy with mefloquine (MQ) reduced malaria rates among pregnant women, yet an unexpected higher risk of mother-to-child transmission (MTCT) of HIV among HIV-positive women receiving MQ has also been observed. To determine if interactions between antiretroviral drugs (ARVs) and MQ could contribute to the increased MTCT observed in women receiving MQ, we performed a retrospective cross-sectional analysis of ARV plasma concentrations in peripheral blood (maternal plasma) and cord blood (cord plasma) collected at delivery from 186 mothers participating in a randomized clinical trial of MQ (n = 102) compared with placebo (n = 84) in Kenya. Plasma zidovudine (AZT), lamivudine (3TC), and nevirapine (NVP) concentrations were measured by high-performance liquid chromatography–tandem mass spectrometry. Although only 4% (7/186) reported not using these ARVs, AZT, 3TC, and NVP were all below the limit of detection in 44% of maternal plasma and 42% of cord plasma samples, and proportions were similar between the two study arms. Median concentrations of AZT and 3TC were not significantly lower in the MQ arm compared with the placebo arm for maternal plasma and cord plasma (p > .05). However, median NVP concentrations were significantly lower in the MQ study arm compared with the placebo study arm in both maternal plasma (1,597 ng/mL vs. 2,353 ng/mL, Mann–Whitney Rank Sum, p = .023) and cord plasma (2,038 ng/mL vs. 2,434 ng/mL, p = .048). Reduced NVP concentrations in maternal and cord plasma of women receiving MQ suggest MQ may affect NVP metabolism for both mother and infant. These results highlight the need to evaluate potential drug–drug interactions between candidate antimalarials and ARVs for use in pregnant women." @default.
• W2940259738 created "2019-04-25" @default.
• W2940259738 creator A5015285519 @default.
• W2940259738 creator A5022330980 @default.
• W2940259738 creator A5027767201 @default.
• W2940259738 creator A5031077639 @default.
• W2940259738 creator A5047090279 @default.
• W2940259738 creator A5057849978 @default.
• W2940259738 creator A5061004254 @default.
• W2940259738 creator A5071666809 @default.
• W2940259738 creator A5078792522 @default.
• W2940259738 creator A5087890790 @default.
• W2940259738 creator A5088444183 @default.
• W2940259738 date "2018-11-01" @default.
• W2940259738 modified "2023-10-08" @default.
• W2940259738 title "Short Communication: Reduced Nevirapine Concentrations Among HIV-Positive Women Receiving Mefloquine for Intermittent Preventive Treatment for Malaria Control During Pregnancy" @default.
• W2940259738 cites W1842023087 @default.
• W2940259738 cites W1982302537 @default.
• W2940259738 cites W2086911097 @default.
• W2940259738 cites W2128052069 @default.
• W2940259738 cites W2129955913 @default.
• W2940259738 cites W2130249510 @default.
• W2940259738 cites W2152609980 @default.
• W2940259738 cites W2158519135 @default.
• W2940259738 cites W2169809284 @default.
• W2940259738 cites W2335638314 @default.
• W2940259738 cites W2787524667 @default.
• W2940259738 doi "https://doi.org/10.1089/aid.2018.0042" @default.
• W2940259738 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6238614" @default.
• W2940259738 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30173559" @default.
• W2940259738 hasPublicationYear "2018" @default.
• W2940259738 type Work @default.
• W2940259738 sameAs 2940259738 @default.
• W2940259738 citedByCount "5" @default.
• W2940259738 countsByYear W29402597382020 @default.
• W2940259738 countsByYear W29402597382022 @default.
• W2940259738 crossrefType "journal-article" @default.
• W2940259738 hasAuthorship W2940259738A5015285519 @default.
• W2940259738 hasAuthorship W2940259738A5022330980 @default.
• W2940259738 hasAuthorship W2940259738A5027767201 @default.
• W2940259738 hasAuthorship W2940259738A5031077639 @default.
• W2940259738 hasAuthorship W2940259738A5047090279 @default.
• W2940259738 hasAuthorship W2940259738A5057849978 @default.
• W2940259738 hasAuthorship W2940259738A5061004254 @default.
• W2940259738 hasAuthorship W2940259738A5071666809 @default.
• W2940259738 hasAuthorship W2940259738A5078792522 @default.
• W2940259738 hasAuthorship W2940259738A5087890790 @default.
• W2940259738 hasAuthorship W2940259738A5088444183 @default.
• W2940259738 hasBestOaLocation W29402597381 @default.
• W2940259738 hasConcept C126322002 @default.
• W2940259738 hasConcept C131872663 @default.
• W2940259738 hasConcept C142462285 @default.
• W2940259738 hasConcept C142724271 @default.
• W2940259738 hasConcept C203014093 @default.
• W2940259738 hasConcept C204787440 @default.
• W2940259738 hasConcept C27081682 @default.
• W2940259738 hasConcept C2777199930 @default.
• W2940259738 hasConcept C2778048844 @default.
• W2940259738 hasConcept C2778371730 @default.
• W2940259738 hasConcept C2779130552 @default.
• W2940259738 hasConcept C2779234561 @default.
• W2940259738 hasConcept C2780216070 @default.
• W2940259738 hasConcept C2780727368 @default.
• W2940259738 hasConcept C2780914630 @default.
• W2940259738 hasConcept C2993143319 @default.
• W2940259738 hasConcept C3013748606 @default.
• W2940259738 hasConcept C54355233 @default.
• W2940259738 hasConcept C71924100 @default.
• W2940259738 hasConcept C86803240 @default.
• W2940259738 hasConcept C90924648 @default.
• W2940259738 hasConceptScore W2940259738C126322002 @default.
• W2940259738 hasConceptScore W2940259738C131872663 @default.
• W2940259738 hasConceptScore W2940259738C142462285 @default.
• W2940259738 hasConceptScore W2940259738C142724271 @default.
• W2940259738 hasConceptScore W2940259738C203014093 @default.
• W2940259738 hasConceptScore W2940259738C204787440 @default.
• W2940259738 hasConceptScore W2940259738C27081682 @default.
• W2940259738 hasConceptScore W2940259738C2777199930 @default.
• W2940259738 hasConceptScore W2940259738C2778048844 @default.
• W2940259738 hasConceptScore W2940259738C2778371730 @default.
• W2940259738 hasConceptScore W2940259738C2779130552 @default.
• W2940259738 hasConceptScore W2940259738C2779234561 @default.
• W2940259738 hasConceptScore W2940259738C2780216070 @default.
• W2940259738 hasConceptScore W2940259738C2780727368 @default.
• W2940259738 hasConceptScore W2940259738C2780914630 @default.
• W2940259738 hasConceptScore W2940259738C2993143319 @default.
• W2940259738 hasConceptScore W2940259738C3013748606 @default.
• W2940259738 hasConceptScore W2940259738C54355233 @default.
• W2940259738 hasConceptScore W2940259738C71924100 @default.
• W2940259738 hasConceptScore W2940259738C86803240 @default.
• W2940259738 hasConceptScore W2940259738C90924648 @default.
• W2940259738 hasIssue "11" @default.
• W2940259738 hasLocation W29402597381 @default.
• W2940259738 hasLocation W29402597382 @default.
• W2940259738 hasLocation W29402597383 @default.
• W2940259738 hasLocation W29402597384 @default.
• W2940259738 hasOpenAccess W2940259738 @default.
• W2940259738 hasPrimaryLocation W29402597381 @default.

• next